Heat shock protein 90 inhibitors. A text book example of medicinal chemistry?

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2005-11-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM050759RPMID 16302791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of 8-demethylgeldanamycin and 4,5-epoxy-8-demethylgeldanamycin from a recombinant strain of Streptomyces hygroscopicus.

  2005cited by this paper
• Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone.

  2005cited by this paper
• Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol

  2005cited by this paper
• The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.

  2005cited by this paper
• Structure-based design of 7-carbamate analogs of geldanamycin.

  2005cited by this paper
• A client‐binding site of Cdc37

  2005cited by this paper
• The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors.

  2005cited by this paper
• Hsp90 inhibitors identified from a library of novobiocin analogues.

  2005cited by this paper
• Regulation of the Dynamics of hsp90 Action on the Glucocorticoid Receptor by Acetylation/Deacetylation of the Chaperone*

  2005cited by this paper
• Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion

  2005cited by this paper
• Crystal structures of human HSP90alpha-complexed with dihydroxyphenylpyrazoles.

  2005cited by this paper
• Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.

  2005cited by this paper
• Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90.

  2005cited by this paper
• Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents.

  2005cited by this paper
• Genetic approaches to polyketide antibiotics. 1.

  2005cited by this paper
• Heat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up?

  2005cited by this paper
• Constantly updated knowledge of Hsp90.

  2005cited by this paper
• Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models

  2005cited by this paper
• Hsp90 and Cdc37 -- a chaperone cancer conspiracy.

  2005cited by this paper
• Preparation of 8-(arylsulfanyl)adenines with diazonium salts under mild, aerobic conditions.

  2005cited by this paper
• HSP90 and the chaperoning of cancer

  2005cited by this paper
• Unveiling the full potential of flexible receptor docking using multiple crystallographic structures.

  2005cited by this paper
• Radester, a novel inhibitor of the Hsp90 protein folding machinery.

  2005cited by this paper
• Design, synthesis, and biological evaluation of HSP90 inhibitors based on conformational analysis of radicicol and its analogues.

  2005cited by this paper
• Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activation.

  2005cited by this paper
• Potent Activity of a Novel Dimeric Heat Shock Protein 90 Inhibitor against Head and Neck Squamous Cell Carcinoma In vitro and In vivo

  2005cited by this paper
• A Two-Hybrid Screen of the Yeast Proteome for Hsp90 Interactors Uncovers a Novel Hsp90 Chaperone Requirement in the Activity of a Stress-Activated Mitogen-Activated Protein Kinase, Slt2p (Mpk1p)

  2005cited by this paper
• Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update

  2005cited by this paper
• Rational design of shepherdin, a novel anticancer agent.

  2005cited by this paper
• Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy.

  2004cited by this paper
• Biotinylated geldanamycin.

  2004cited by this paper
• Synthesis and biological activities of novel 17-aminogeldanamycin derivatives.

  2004cited by this paper
• Modular asymmetric synthesis of pochonin C.

  2004cited by this paper
• Inhibition of Hsp90: a new strategy for inhibiting protein kinases.

  2004cited by this paper
• Hsp90 isoforms: functions, expression and clinical importance

  2004cited by this paper
• New efficient synthesis of resorcinylic macrolides via ynolides: establishment of cycloproparadicicol as synthetically feasible preclinical anticancer agent based on Hsp90 as the target.

  2004cited by this paper
• Altered Hsp90 function in cancer: a unique therapeutic opportunity.

  2004cited by this paper
• Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition.

  2004cited by this paper
• Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent

  2004cited by this paper
• Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.

  2004cited by this paper
• Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.

  2004cited by this paper
• Hsp90: the vulnerable chaperone.

  2004cited by this paper
• Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90.

  2004cited by this paper
• Altered states: selectively drugging the Hsp90 cancer chaperone.

  2004cited by this paper
• Geldanamycin Analogs

  2004cited by this paper
• Recent developments in the maytansinoid antitumor agents.

  2004cited by this paper
• Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding.

  2004cited by this paper
• Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.

  2004cited by this paper
• New monordens produced by amidepsine-producing fungus Humicola sp. FO-2942.

  2003cited by this paper
• Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol.

  2003cited by this paper
• Total synthesis as a resource in the discovery of potentially valuable antitumor agents: cycloproparadicicol.

  2003cited by this paper
• Peptides with anticancer use or potential

  2003cited by this paper
• A Resorcylic Acid Lactone, 5Z-7-Oxozeaenol, Prevents Inflammation by Inhibiting the Catalytic Activity of TAK1 MAPK Kinase Kinase*

  2003cited by this paper
• Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90.

  2003cited by this paper
• Synthesis of novel fluorescent probes for the molecular chaperone Hsp90.

  2003cited by this paper
• A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

  2003cited by this paper
• Development of purine-scaffold small molecule inhibitors of Hsp90.

  2003cited by this paper
• The C-terminal half of heat shock protein 90 represents a second site for pharmacologic intervention in chaperone function.

  2003cited by this paper
• Development of radicicol analogues.

  2003cited by this paper
• SPANphos: a C2-symmetric trans-coordinating diphosphane ligand.

  2003cited by this paper
• Structure of the N-terminal Domain of GRP94

  2003cited by this paper
• Auditing the pharmacological accounts for Hsp90 molecular chaperone inhibitors: unfolding the relationship between pharmacokinetics and pharmacodynamics.

  2003cited by this paper
• Pochonins A-F, new antiviral and antiparasitic resorcylic acid lactones from Pochonia chlamydosporia var. catenulata.

  2003cited by this paper
• Flavopiridol, a Novel Cyclin-Dependent Kinase Inhibitor, in Clinical Development

  2002cited by this paper
• Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase.

  2002cited by this paper
• Inhibition of branched-chain alpha-keto acid dehydrogenase kinase and Sln1 yeast histidine kinase by the antifungal antibiotic radicicol.

  2002cited by this paper
• Hsp90 inhibitors as novel cancer chemotherapeutic agents.

  2002cited by this paper
• Binding of ATP to Heat Shock Protein 90

  2002cited by this paper
• HSP90 as a new therapeutic target for cancer therapy: the story unfolds

  2002cited by this paper
• Halohydrin and oxime derivatives of radicicol: synthesis and antitumor activities.

  2002cited by this paper
• Hsp90: Chaperoning signal transduction

  2001cited by this paper
• A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells.

  2001cited by this paper
• Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats

  2001cited by this paper
• LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family.

  2001cited by this paper
• Stereospecific antitumor activity of radicicol oxime derivatives

  2001cited by this paper
• Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status

  2000cited by this paper
• The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the Chaperone*

  2000cited by this paper
• GHKL, an emergent ATPase/kinase superfamily.

  2000cited by this paper
• Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.

  2000cited by this paper
• Discovery of novel ansamycins possessing potent inhibitory activity in a cell-based oncostatin M signalling assay.

  2000cited by this paper
• Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.

  2000cited by this paper
• Synthesis and evaluation of geldanamycin-testosterone hybrids.

  2000cited by this paper
• Reblastatin, a novel benzenoid ansamycin-type cell cycle inhibitor.

  2000cited by this paper
• Radicicol Binds and Inhibits Mammalian ATP Citrate Lyase*

  2000cited by this paper
• Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases.

  2000cited by this paper
• Synthesis and evaluation of geldanamycin-estradiol hybrids.

  1999cited by this paper
• KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.

  1999cited by this paper
• Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.

  1999cited by this paper
• Resorcylic acid lactones: naturally occurring potent and selective inhibitors of MEK.

  1999cited by this paper
• A radicicol-related macrocyclic nonaketide compound, antibiotic LL-Z1640-2, inhibits the JNK/p38 pathways in signal-specific manner.

  1999cited by this paper
• Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol

  1998cited by this paper
• Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.

  1998cited by this paper
• Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver.

  1998cited by this paper
• Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.

  1998cited by this paper
• Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.

  1997cited by this paper
• Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.

  1995cited by this paper
• erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.

  1995cited by this paper
• Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

  1994cited by this paper
• Binding of benzoquinoid ansamycins to p100 correlates with their ability to deplete the erbB2 gene product p185.

  1994cited by this paper
• Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol.

  1992cited by this paper

• Extracting Atomic Contributions to Binding Free Energy Using Molecular Dynamics Simulations with Mixed Solvents (MDmix)

  2022cites this paper
• Extracting Atomic Contributions to Binding Free Energy using Molecular Dynamics Simulations with Mixed Solvents (MDmix)

  2021cites this paper
• Molecular modeling studies of the effects of withaferin A and its derivatives against oncoproteins associated with breast cancer stem cell activity

  2021cites this paper
• Are Hsp90 inhibitors good candidates against Covid-19?

  2020cites this paper
• Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer

  2017cites this paper
• Total Synthesis of (+)-Pochonin D and (+)-Monocillin II via Chemo- and Regioselective Intramolecular Nitrile Oxide Cycloaddition.

  2017cites this paper
• Marine-Derived Penicillium Species as Producers of Cytotoxic Metabolites

  2017cites this paper
• Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors.

  2017cites this paper
• IONIC LIQUIDS AS SOLVENTS AND CATALYSTS FOR THE GREEN SYNTHESIS OF COUMARINS

  2016cites this paper
• HSP90 Stabilizes Auxin-Responsive Phenotypes by Masking a Mutation in the Auxin Receptor TIR1.

  2016cites this paper
• Cross‐Coupling of Heteroarenes by CH Functionalization: Recent Progress towards Direct Arylation and Heteroarylation Reactions Involving Heteroarenes Containing One Heteroatom

  2014cites this paper
• Heat shock protein 90 as a potential drug target against surra

  2014cites this paper
• Synthesis of macrolactam analogues of radicicol and their binding to heat shock protein Hsp90.

  2014cites this paper
• Studies towards the total synthesis of hygrocins A and B

  2014cites this paper
• Exploiting Cancer Dependence on Molecular Chaperones: HSP90 Inhibitors Past, Present, and Future

  2014cites this paper
• Discovery and Bioevaluation of Novel Pyrazolopyrimidine Analogs as Competitive Hsp90 Inhibitors Through Shape‐Based Similarity Screening

  2014cites this paper
• Hybrids of the Benzofuran Core from Natural Products and the 2,4‐Dihydroxy‐5‐isopropylbenzene Fragment as Potent Hsp90 Inhibitors: Design, Synthesis and Bioevaluation

  2014cites this paper
• Protein chaperones: a composition of matter review (2008 – 2013)

  2014cites this paper
• Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism.

  2014cites this paper
• Synthesis of a cytotoxic ansamycin hybrid.

  2014cites this paper
• A biochemical screen for GroEL/GroES inhibitors.

  2014cites this paper
• 4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors.

  2014cites this paper
• Natural product chemistry and anticancer drug discovery

  2014cites this paper
• Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.

  2013cites this paper
• Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90.

  2013cites this paper
• Bioreduction of aryl azides during mutasynthesis of new ansamitocins.

  2013cites this paper
• Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening.

  2013cites this paper
• In Silico Fragment-Based Drug Discovery: Setup and Validation of a Fragment-to-Lead Computational Protocol Using S4MPLE

  2013cites this paper
• Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90.

  2013cites this paper
• Synthesis of the naphthoquinone core of divergolides (C–D) and model studies for elaboration of the ansabridge

  2013cites this paper
• Synthesis of carbohydrate fused chiral macrocyclic benzolactones through Sonogashira reaction

  2013cites this paper
• Dual inhibition of chaperoning process by taxifolin: molecular dynamics simulation study.

  2012cites this paper
• Structural characterization of tetranortriterpenes from Pseudrocedrela kotschyi and Trichilia emetica and study of their activity towards the chaperone Hsp90.

  2012cites this paper
• Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.

  2012cites this paper
• Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3

  2012cites this paper
• Preparation and chemistry of 3/5-halogenopyrazoles.

  2012cites this paper
• Monocillin II Inhibits Human Breast Cancer Growth Partially by Inhibiting MAPK Pathways and CDK2 Thr160 Phosphorylation

  2012cites this paper
• Asymmetric synthesis of pochonin E and F, revision of their proposed structure, and their conversion to potent Hsp90 inhibitors.

  2012cites this paper
• Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90.

  2012cites this paper
• Broad substrate specificity of the amide synthase in S. hygroscopicus--new 20-membered macrolactones derived from geldanamycin.

  2012cites this paper
• In vitro Studie zur Effektivität von Hsp90-Inhibitoren bei der Therapie des Ösophaguskarzinoms

  2012cites this paper
• HSP90 as a platform for the assembly of more effective cancer chemotherapy.

  2012cites this paper
• InCl3 catalyzed domino route to 2H-chromene-2-ones via [4 + 2] annulation of 2-hydroxyarylaldehydes with α-oxoketene dithioacetal under solvent-free conditions

  2012cites this paper
• Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies

  2012cites this paper
• Inhibiting HSP90 to treat cancer: a strategy in evolution.

  2012cites this paper
• Molecular Dynamics Simulations of Hsp90 with an Eye to Inhibitor Design

  2012cites this paper
• A pair of sulfur-containing geldanamycin analogs, 19-S-methylgeldanamycin and 4,5-dihydro- 19-S-methylgeldanamycin, from Streptomyces hygroscopicus 17997

  2011cites this paper
• Discovery and Biological Activity of 6BrCaQ as an Inhibitor of the Hsp90 Protein Folding Machinery

  2011cites this paper
• Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.

  2011cites this paper
• Lead identification of β-lactam and related imine inhibitors of the molecular chaperone heat shock protein 90.

  2011cites this paper
• The Literature of Heterocyclic Chemistry, Part X, 2005–2007

  2011cites this paper
• Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation

  2011cites this paper
• A High-Throughput TNP-ATP Displacement Assay for Screening Inhibitors of ATP-Binding in Bacterial Histidine Kinases

  2011cites this paper
• Potential of Heat Shock Protein Targeting for Human Therapy

  2011cites this paper
• Withaferin A targets heat shock protein 90 in pancreatic cancer cells.

  2010cites this paper
• Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90.

  2010cites this paper
• Stereoselective Total Synthesis of (11β)-11-Methoxycurvularin

  2010cites this paper
• A Simple Synthesis of Functionalized 3‐Bromocoumarins by a One‐Pot Three‐Component Reaction

  2010cites this paper
• Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors

  2010cites this paper
• Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.

  2010cites this paper
• From the bench to the bed side: PI3K pathway inhibitors in clinical development.

  2010cites this paper
• Many pharmaceutical companies are sponsoring clinical trials of inhibitors of HSP 90 ATPase

  2010cites this paper
• 2 PI 3 K Inhibitors : Path to the Clinic 2 . 1 PI 3 K Inhibitors in Oncology Drug Discovery and Development

  2010cites this paper
• 5-Iodo-3-ethoxypyrazoles: an entry point to new chemical entities.

  2010cites this paper
• Targeting the Hsp90 chaperone: synthesis of novel resorcylic acid macrolactone inhibitors of Hsp90.

  2010cites this paper
• Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors

  2010cites this paper
• Probing the influence of an allylic methyl group in zearalenone analogues on binding to Hsp90.

  2010cites this paper
• Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design.

  2010cites this paper
• Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency.

  2010cites this paper
• ATPase inhibitors of heat-shock protein 90, second season.

  2010cites this paper
• A one-pot [Bmim]OH-mediated synthesis of 3-benzamidocoumarins

  2009cites this paper
• Peptide Microarrays

  2009cites this paper
• Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells.

  2009cites this paper
• Mactinin, a fragment of cytoskeletal α-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation

  2009cites this paper
• Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone.

  2009cites this paper
• Heat shock protein 90 is involved in regulation of hypoxia-driven proliferation of embryonic neural stem/progenitor cells

  2009cites this paper
• Molecular simulations of peptides: a useful tool for the development of new drugs and for the study of molecular recognition.

  2009cites this paper
• New, Highly Active Nonbenzoquinone Geldanamycin Derivatives by Using Mutasynthesis

  2009cites this paper
• Propionate Analogues of Zearalenone Bind to Hsp90

  2009cites this paper
• Natural product inhibitors of Hsp90: potential leads for drug discovery.

  2009cites this paper
• Synthesis of 3-aryl-8-oxo-5,6,7,8-tetrahydroindolizines via a palladium-catalyzed arylation and heteroarylation.

  2009cites this paper
• Solution-phase parallel synthesis of Hsp90 inhibitors.

  2009cites this paper
• Hsp90 inhibition with resorcyclic acid lactones (RALs).

  2009cites this paper
• HSP90 Inhibition as an Anticancer Strategy: Novel Approaches and Future Directions

  2009cites this paper
• Human 90 kDa Heat Shock Protein Hsp90 as a Target for Cancer Therapeutics

  2009cites this paper
• Peptide Microarrays: Methods and Protocols

  2009cites this paper
• Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.

  2008cites this paper
• Design and synthesis of ansamycin antibiotics

  2008cites this paper
• Natural Products as Anticancer Agents

  2008cites this paper
• Alternative and expedient asymmetric syntheses of L-(+)-noviose.

  2008cites this paper
• The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ.

  2008cites this paper
• NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis.

  2008cites this paper
• Crystal structure of 3-[(2,2-dimethylchroman-6-yl)carbonylamino]-7-hydroxy- 8-methyl-2-oxo-2H-chromen-4-yl toluene-4-sulfonate, C29H27NO8S

  2008cites this paper
• Drug discovery approaches targeting the PI3K/Akt pathway in cancer

  2008cites this paper
• Understanding ligand-based modulation of the Hsp90 molecular chaperone dynamics at atomic resolution

  2008cites this paper
• Apralactone A and a New Stereochemical Class of Curvularins from the Marine-Derived Fungus Curvularia sp.

  2008cites this paper
• CHAPTER 5 – Natural product chemistry and anticancer drug discovery

  2008cites this paper
• Medicinal chemistry of Hsp90 inhibitors.

  2008cites this paper
• HIF-1α and STAT3 client proteins interacting with the cancer chaperone Hsp90: Therapeutic considerations

  2008cites this paper
• Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA

  2008cites this paper